News & Events


  • August 17, 2016
    Posted by: Jamie Zacher, PharmD

    Health literacy is especially important in clinical trials. Any misunderstanding of information by patients may lead to medication errors, failure to follow protocol instructions, lower compliance rates, and poor outcomes for the study. An estimated 90 million American adults have poor health literacy and struggle with reading, understanding, and using the health information presented to […]

  • August 8, 2016
    Posted by: Jamie Zacher, PharmD

    Medication compliance is extremely important in clinical trials. Scientists estimate that the average medication compliance rate among trial patients is as low as 43 percent (1). With such low rates of compliance, it can be difficult to show the effectiveness of a medication. As a result, in order for sponsors to get their medications to […]

  • August 2, 2016
    Posted by: Tina Schlecht, PharmD, MBA

    Some years back, at the beginning of a Phase 3 trial, it was discovered that the study medication instructions had been printed incorrectly in one of the study aids. The instructions stated that patients should take the medication before breakfast and before dinner. In most regions of the U.S., dinner is a meal taken in […]

  • July 26, 2016
    Posted by: Tina Schlecht, PharmD, MBA

    Medication compliance in clinical research is so much more than the instructions on the kit and tracking whether the patient is or is not taking each dose. According to a report by the Institute of Medicine (IOM), approximately half of all American adults (90 million people) have trouble reading, understanding, and using health information properly. […]

  • July 19, 2016
    Posted by: Joe Martinez, RPh, PDE, PPC

    Patient-centricity is providing a vehicle for global clinical research professionals to improve the feasibility and outcomes of clinical trials. The International Society for Pharmaceutical Engineering (ISPE) engaged the Center for Information and Study on Clinical Research Participation (CISCRP) to conduct a study to assess the patient experience with clinical trial medicine kits in terms of […]

  • July 12, 2016
    Posted by: Joe Martinez, RPh, PDE, PPC

    While the demand for Comparative Effectiveness Research (CER) data is increasing and will continue to increase for the foreseeable future, managed care decision-makers need both clinical and economic data to make informed formulary and coverage decisions. If the company doesn’t provide this type of information in the form of randomized controlled trial (RCT) data, the […]

  • July 6, 2016
    Posted by: Joe Martinez, RPh, PDE, PPC

    The practice of pharmacy has always centered on the patient.   Lately, however, ‘patient-centricity’ is gaining more visibility and momentum in the media, clinical industry and with regulatory authorities as a way to improve trial enrollment, patient retention and study outcomes.

  • June 19, 2016
    Posted by: Tina Schlecht, PharmD, MBA

    Taking medications is hard. Following study protocol instructions correctly is even harder. Patients who have trouble with medication compliance in a clinical trial are more likely to become discouraged, and less likely to see the trial through to completion. According to research by Tufts Center for the Study of Drug Development, only half of the […]

  • Case Study
    A Biopharmaceutical Company Sponsoring a Phase III Clinical Trial in the U.S.
  • Latest News
    Center Point Clinical Services Names Gerald E. Finken New CEO
    March 15, 2018
  • Need More Information?